Why Novavax is different to other vaccines and some Australians have 'held out' for it
The Novavax COVID-19 vaccine has been provisionally approved by Australia after showing promising results in clinical trials. With more than 90 per cent of the country now vaccinated, there are hopes its approval will convince the remaining vaccine-hesitant few to finally get jabbed.
Novavax illustration Source: SBS News
Share
1 min read
Published 24 January 2022 5:10pm
Presented by SBS Nepali
Source: SBS
Share this with family and friends